Go Pro

Dimensional Fund Advisors LP Raises Holdings in Anterix Inc. $ATEX

Anterix logo with Communication Services background
Image from MarketBeat Media, LLC.

Dimensional Fund Advisors LP boosted its position in Anterix Inc. (NASDAQ:ATEX - Free Report) by 30.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 424,856 shares of the company's stock after purchasing an additional 99,933 shares during the quarter. Dimensional Fund Advisors LP owned about 2.27% of Anterix worth $16,223,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of ATEX. Jefferies Financial Group Inc. purchased a new position in Anterix during the fourth quarter worth approximately $9,922,000. Millennium Management LLC grew its holdings in shares of Anterix by 1,153.1% in the fourth quarter. Millennium Management LLC now owns 439,946 shares of the company's stock valued at $9,604,000 after purchasing an additional 404,838 shares during the period. Gamco Investors INC. ET AL grew its holdings in shares of Anterix by 32.0% in the fourth quarter. Gamco Investors INC. ET AL now owns 422,470 shares of the company's stock valued at $9,223,000 after purchasing an additional 102,400 shares during the period. State Street Corp increased its position in Anterix by 5.4% during the fourth quarter. State Street Corp now owns 333,788 shares of the company's stock worth $7,287,000 after purchasing an additional 17,017 shares during the last quarter. Finally, Gabelli Funds LLC raised its stake in Anterix by 6.5% during the fourth quarter. Gabelli Funds LLC now owns 304,907 shares of the company's stock worth $6,656,000 after purchasing an additional 18,625 shares during the period. 87.67% of the stock is currently owned by institutional investors and hedge funds.

Anterix Price Performance

NASDAQ:ATEX opened at $99.26 on Friday. The firm has a market capitalization of $1.94 billion, a PE ratio of 20.51 and a beta of 0.85. The business's fifty day moving average price is $90.09 and its 200 day moving average price is $57.80. Anterix Inc. has a 12 month low of $17.58 and a 12 month high of $113.00.

Insider Activity

In other Anterix news, insider Christopher Guttman-Mccabe sold 91,437 shares of the firm's stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $82.46, for a total transaction of $7,539,895.02. Following the transaction, the insider owned 77,807 shares of the company's stock, valued at approximately $6,415,965.22. This trade represents a 54.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Mark Fleischhauer sold 3,500 shares of Anterix stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $79.83, for a total value of $279,405.00. Following the sale, the director owned 12,769 shares in the company, valued at $1,019,349.27. This trade represents a 21.51% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 124,109 shares of company stock valued at $10,174,158 over the last 90 days. Insiders own 40.05% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on ATEX shares. Weiss Ratings raised Anterix from a "hold (c)" rating to a "hold (c+)" rating in a research note on Friday, June 26th. Clear Str raised Anterix to a "strong-buy" rating in a research report on Monday, July 27th. B. Riley Financial lowered shares of Anterix from a "buy" rating to a "neutral" rating and boosted their price objective for the company from $44.00 to $69.00 in a report on Thursday, June 4th. Wall Street Zen raised shares of Anterix from a "sell" rating to a "hold" rating in a research report on Saturday, June 27th. Finally, JPMorgan Chase & Co. increased their target price on shares of Anterix from $50.00 to $133.00 and gave the stock an "overweight" rating in a research note on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Anterix currently has an average rating of "Moderate Buy" and a consensus target price of $101.00.

Check Out Our Latest Analysis on Anterix

Anterix Company Profile

(Free Report)

Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.

At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.

Further Reading

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Anterix Right Now?

Before you consider Anterix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.

While Anterix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines